Brief: LIDDS And Pharmidea Sign Manufacturing Agreement

Lidds AB

25/02/2021 07:36

Feb 25 (Reuters) - Lidds AB  LIDDS.ST :
    * LIDDS AND PHARMIDEA SIGNS MANUFACTURING AGREEMENT
    * DEVELOPMENT OF NZ-TLR9 FORMULATION WILL BE FIRST PROJECT
WITHIN
COLLABORATION BETWEEN LIDDS AND PHARMIDEA.
    * IS PREPARING A CLINICAL PHASE I TRIAL WITH INTRATUMORAL
INJECTIONS OF NZ-TLR9 FOR TREATMENT OF SOLID TUMORS IN PATIENTS
WITH HEAD/NECK-, BREAST CANCER, MELANOMA, SARCOMAS AND LYMPHOMAS
    * DEVELOPMENT OF NZ-TLR9 FORMULATION WILL BE FIRST PROJECT
WITHIN
COLLABORATION BETWEEN LIDDS AND PHARMIDEA.

Source text for Eikon:  ID:nGNE9wSckB 
Further company coverage:  LIDDS.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))